You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 7,858,605


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,858,605
Title:Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Abstract:This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Inventor(s): Bell; Robert G. (Palm Harbor, FL), Ben-Maimon; Carole (Merion, PA), Iskold; Beata (Livingston, NJ)
Assignee: Teva Women's Health, Inc. (Woodcliff Lake, NJ)
Application Number:11/951,492
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,858,605
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,858,605: A Comprehensive Analysis

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for inventors, patent practitioners, and businesses. This article will provide a detailed analysis of the scope and claims of United States Patent 7,858,605, highlighting key aspects of patent law, claim management, and the broader patent landscape.

Overview of Patent 7,858,605

To begin with, it is essential to identify the subject matter of the patent. However, since the specific details of Patent 7,858,605 are not provided in the sources, we will use general principles and examples to illustrate how to analyze the scope and claims of a patent.

Patent Scope: Definition and Importance

Patent scope refers to the breadth and depth of protection afforded by a patent. It is a critical aspect of patent law, as it determines what is covered by the patent and what is not. The scope is primarily defined by the claims section of the patent, which outlines the specific features and limitations of the invention[3].

Claim Structure and Types

Independent Claims

Independent claims are standalone claims that define the invention without referencing other claims. They are crucial because they set the broadest boundaries of the patent's scope. For example, in the context of pharmaceutical compositions, an independent claim might define the specific combination of active ingredients and their proportions[1].

Dependent Claims

Dependent claims, on the other hand, refer back to an independent claim and further limit the scope by adding additional features or constraints. These claims help to narrow down the invention and provide additional protection against potential infringers[5].

Claim Management Strategies

Effective claim management is vital for maximizing the value of a patent. Here are some strategies:

Consolidating Claims

During the patent prosecution phase, it is common to consolidate multiple dependent claims into fewer, broader independent claims. This approach can facilitate application approval and strengthen the patent's overall scope[5].

Utilizing the Full Quota of Claims

The initial patent application filing fee in the United States covers up to 3 independent claims and a total of 20 claims. Ensuring that the final patent utilizes this full quota by adding new dependent claims for every canceled claim can enhance the patent's breadth and flexibility without additional costs[5].

Metrics for Measuring Patent Scope

Researchers have developed metrics to quantify patent scope, which can be useful in evaluating the strength and breadth of a patent.

Independent Claim Length and Count

Studies have shown that independent claim length and the number of independent claims can serve as simple yet effective metrics for measuring patent scope. These metrics have explanatory power for several correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Patent Prosecution Process

The patent prosecution process involves several stages where the claims of a patent are scrutinized and often amended.

Examination Process

During the examination process, the USPTO evaluates the patentability of the claims. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Amending Claims

It is not uncommon to amend claims to align with USPTO requirements. This may involve consolidating dependent claims into broader independent claims or adding new dependent claims to ensure comprehensive protection[5].

Economic and Strategic Implications

The strategic management of claims has significant economic and strategic implications.

Licensing and Infringement

A well-managed set of claims can enhance the defensive capabilities of a patent and increase its value in licensing discussions or infringement disputes. Each claim can be viewed as a unique tool for protecting different facets of the invention[5].

Client Value

Demonstrating meticulous and value-driven management of intellectual property through strategic claim management can differentiate a patent’s quality and potential for commercial success. This approach reinforces the importance of detail-oriented strategies in patent law[5].

Case Studies and Examples

While specific details of Patent 7,858,605 are not available, we can look at other patents for illustrative purposes.

Pharmaceutical Compositions

For instance, Patent 6,500,867, which involves a pharmaceutical composition comprising entacapone, levodopa, and carbidopa, demonstrates how independent and dependent claims are structured to protect a specific combination of active ingredients[1].

Data and Statistics

The USPTO's Patent Claims Research Dataset provides valuable insights into patent claims and scope. This dataset includes detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. It highlights trends and metrics that can be used to analyze patent scope and claim management strategies[2].

Conclusion

Understanding the scope and claims of a patent is essential for maximizing its value and ensuring comprehensive protection of the invention. By leveraging strategic claim management, utilizing the full quota of claims, and understanding metrics for measuring patent scope, inventors and patent practitioners can enhance the defensive capabilities and commercial potential of their patents.

Key Takeaways

  • Patent Scope: Defined by the claims section, it determines the breadth and depth of protection.
  • Claim Structure: Independent claims set the broadest boundaries, while dependent claims further limit the scope.
  • Claim Management: Consolidating claims, utilizing the full quota, and amending claims during prosecution can enhance patent value.
  • Metrics for Patent Scope: Independent claim length and count are useful metrics.
  • Economic Implications: Well-managed claims can increase patent value in licensing and infringement contexts.

FAQs

Q: What is the primary determinant of a patent's scope? A: The primary determinant of a patent's scope is the claims section of the patent.

Q: How many independent and total claims are covered by the initial patent application filing fee in the United States? A: The initial patent application filing fee covers up to 3 independent claims and a total of 20 claims.

Q: Why is it important to utilize the full quota of claims in a patent application? A: Utilizing the full quota of claims can enhance the patent's breadth and flexibility without incurring additional costs.

Q: What metrics are commonly used to measure patent scope? A: Independent claim length and the number of independent claims are commonly used metrics.

Q: How does the examination process affect the claims of a patent? A: During the examination process, claims may be amended to align with USPTO requirements, and narrower claims at publication are associated with a higher probability of grant and a shorter examination process.

Sources

  1. DrugPatentWatch - Summary for Patent: 6,500,867
  2. USPTO - Patent Claims Research Dataset
  3. SSRN - Patent Claims and Patent Scope
  4. Google APIs - United States Patent 8,415,332 B2
  5. Harrity LLP - Maximizing Patent Value: A Strategic Approach to Claim Management

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,858,605

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,858,605

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1453521 ⤷  Subscribe 122015000093 Germany ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe CA 2016 00016 Denmark ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe 93156 Luxembourg ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe 300814 Netherlands ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe C20160011 00192 Estonia ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe 39/2015 Austria ⤷  Subscribe
European Patent Office 1453521 ⤷  Subscribe 15C0050 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.